1. MO-0713 Stereotactic Body Radiotherapy for Long Bone Metastases: An International Multicenter Analysis. (May 2022) Authors: Madani, I.; Guckenberger, M.; Erler, D.; Stish, B.J.; Olivier, K.R.; Park, S.S.; Eppinga, W.; Seravalli, E.; Redmond, K.J.; Cao, Y.; Siva, S.; Chang, D.; Nguyen, T.K.; O'Neil, M.; Sahgal, A. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S623 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Outcomes and toxicities in oligometastatic patients treated with stereotactic body radiotherapy for adrenal gland metastases: A multi-institutional retrospective study. (March 2022) Authors: Baydoun, A.; Chen, H.; Poon, I.; Badellino, S.; Dagan, R.; Erler, D.; Foote, M.C.; Louie, A.V.; Redmond, K.J.; Ricardi, U.; Sahgal, A.; Biswas, T. Journal: Clinical and translational radiation oncology Issue: Volume 33(2022) Page Start: 159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PD-0845 Stereotactic radiotherapy for oligometastatic NSCLC: results from the multicenter CORE consortium. (August 2021) Authors: Badellino, S.; Chen, H.; Poon, I.; Erler, D.; Levis, M.; Dagan, R.; Foote, M.; Louie, A.V.; Redmond, K.J.; Biswas, T.; Sahgal, A.; Ricardi, U. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S679 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗